Scientists presented a light-sheet fluorescence microscopy approach to image the pancreas in 3D and map tissue interactions at key time points in the mouse embryo.
[Development]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
Category Archives: Pancreatic Cell
Pancreatic Cell NewsPancreatic Cell News is an online publication and email newsletter providing updates on the latest pancreatitis, diabetes, and pancreatic cancer research.
Pancreatic Cell News is a weekly newsletter that highlights recent top articles in the field of pancreatic cell research. These articles have been carefully selected from high-impact, peer-reviewed academic journals by our experienced editorial team. We cover topics including pancreatic cell culture, pancreatitis, diabetes, and pancreatic cancer. We also feature the latest industry and policy news alongside job postings and upcoming events to keep scientists current while saving them valuable time.
Development of a 3D Atlas of the Embryonic Pancreas for Topological and Quantitative Analysis of Heterologous Cell Interactions
The Idd2 Locus Confers Prominent Resistance to Autoimmune Diabetes
Researchers generated a NOD congenic mouse bearing B10 resistance alleles on chromosome 9 in a locus coinciding with part of the insulin-dependent diabetes (Idd) locus and found that NOD.
[Journal of Immunology]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
Aminopyridine Analogs Selectively Target Metastatic Pancreatic Cancer
6-aminopicolamine (6AP) acted as a water-soluble prodrug that was converted into intracellular bioactive metabolites that inhibited phosphogluconate dehydrogenase in vitro, and 6AP monotherapy demonstrated anti-metastatic efficacy with minimal toxicity in vivo.
[Oncogene]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
Zai Lab Announces First Patient Treated in Greater China in PANOVA-3 Phase III Pivotal Trial of Tumor Treating Fields in Pancreatic Cancer
Zai Lab Limited announced treatment of the first patient in Greater China in the PANOVA-3 trial, a Phase III pivotal trial of Tumor Treating Fields in patients with pancreatic cancer.
[Zai Lab Limited]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
Analysis of the Glyco-Code in Pancreatic Ductal Adenocarcinoma Identifies Glycan-Mediated Immune Regulatory Circuits
By analysing publicly available transcriptomic data of patient samples and cell lines, researchers identified here two specific glycan profiles in pancreatic ductal adenocarcinoma that correlated with progression, clinical outcome and epithelial to mesenchymal transition status.
[Communications Biology]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
Multimodal Evaluation of 19F-BPA Internalization in Pancreatic Cancer Cells for Boron Capture and Proton Therapy Potential Applications
Researchers evaluated the in vitro internalization of the 19F-labelled p-boronophenylalanine (19F-BPA) in the human cancer pancreatic cell line for the potential application of Boron Neutron Capture Therapy and Proton Boron Fusion Therapy in pancreatic cancer.
[Physica Medica-European Journal of Medical Physics]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
Inter-Organ Crosstalk in Pancreatic Islet Function and Pathology
Scientists discuss recent advances in inter-organ communication from the metabolic, immune, and neural system to pancreatic islets, their biological implication in normal pancreas endocrine function, as well as their role in the adaptive responses of islet to nutrition-induced stress.
[Febs Letters]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to Fuel Tumour Progression
Grainyhead 1 Acts as a Drug-Inducible Conserved Transcriptional Regulator Linked to Insulin Signaling and Lifespan
Researchers showed that increased expression of the transcription factor Grainyhead 1 promoted lifespan and pathogen resistance in Caenorhabditis elegans.
[Nature Communications]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
Biomea Fusion Announces 2022 Clinical Development Plan to Initiate Studies in Up to Seven Different Tumor Types and in Diabetes for BMF-219
Biomea Fusion, Inc. announced that in 2022 it plans to initiate clinical studies to dose its irreversible covalent menin inhibitor, BMF-219, in up to seven different cancer indications as well as in diabetes.
[Biomea Fusion, Inc.]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
Organization and Dynamics of the Cortical Complexes Controlling Insulin Secretion in β-Cells
Researchers showed that insulin secretion sites also contain non-neuronal proteins LL5β and KANK1, which in migrating cells organize exocytotic machinery in the vicinity of integrin-based adhesions.
[Journal of Cell Science]
[zotpress userid=” items=’AAAAAAAA’ style=’apa’ cite=’yes’]
